Related Experiment Video
Updated: Aug 7, 2026
08:02
Fecal Glucocorticoid Analysis: Non-invasive Adrenal Monitoring in Equids
Published on: April 25, 2016
[Glucocorticoids and sport's performance]
1Departamento de Bioquímica, Biología Molecular y Fisiología, Escuela Universitaria Fisioterapia, Universidad Valladolid, Soria, Spain. a.cordova@bio.uva.es
Revista Clinica Espanola
|July 26, 2006
Summary
Glucocorticoids, derived from hydrocortisone, have anti-inflammatory and immunosuppressive effects. Studies show these corticosteroids do not improve athletic performance, even with described benefits at rest.
Area of Science:
- Endocrinology and Pharmacology
- Exercise Physiology
Context:
- Glucocorticoids, including hydrocortisone, are endogenous and exogenous hormones with significant physiological and pharmacological roles.
- Their primary effects include anti-inflammatory and immunosuppressive actions, with potential secondary effects that are minimal under medical supervision.
Purpose:
- To investigate the effects of glucocorticoids on athletic performance.
- To determine if described benefits like anti-inflammatory and anxiolytic effects in resting individuals translate to enhanced exercise performance.
Summary:
- Glucocorticoids exhibit anti-inflammatory and immunosuppressive properties.
- While certain benefits (anti-inflammatory, antialgic, anxiolytic, antiasthenic) are noted in resting patients, these effects lack confirmation in individuals undergoing exercise.
- Research analyzing glucocorticoid impact on sports performance indicates no discernible improvement.
Impact:
- Clarifies the limited evidence for performance enhancement by glucocorticoids in exercise settings.
- Highlights the distinction between effects at rest versus during physical exertion.
- Provides crucial information for athletes and medical professionals regarding the efficacy of corticosteroids in sports.
Related Concept Videos
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:16Hormones Regulating Blood Glucose
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
In addition to accelerating glucose uptake and utilization, insulin has...
01:19Cushing Syndrome II: Pathophysiology
Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...